Steven Cohen's NGNE Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 141,920 shares of Neurogene Inc. (NGNE) worth $4.46 M, representing 0.00% of the portfolio. First purchased in 2024-Q1, this short-term holding has been held for 5 quarters.
Based on 13F filings, Steven Cohen has maintained this position in NGNE for several quarters, showing initial confidence in the investment. Largest addition occurred in Q2 2026, adding 141,920 shares. Largest reduction occurred in Q2 2024, reducing 28,033 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Neurogene (NGNE) Holding Value Over Time
Track share changes against reported price movement
Quarterly Neurogene (NGNE) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +141,920 | New Buy | 141,920 | $31.45 |
| Q4 2025 | -7,669 | Sold Out | 0 | $0.00 |
| Q3 2025 | +7,669 | New Buy | 7,669 | $17.33 |
| Q2 2024 | -28,033 | Sold Out | 0 | $0.00 |
| Q1 2024 | +28,033 | New Buy | 28,033 | $50.90 |
Steven Cohen's Neurogene Investment FAQs
Steven Cohen first purchased Neurogene Inc. (NGNE) in Q1 2024, acquiring 28,033 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Neurogene Inc. (NGNE) for 5 quarters since Q1 2024.
Steven Cohen's largest addition to Neurogene Inc. (NGNE) was in Q2 2026, adding 141,920 shares worth $4.46 M.
According to the latest 13F filing for Q2 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 141,920 shares of Neurogene Inc. (NGNE), valued at approximately $4.46 M.
As of the Q2 2026 filing, Neurogene Inc. (NGNE) represents approximately 0.00% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Neurogene Inc. (NGNE) was 141,920 shares, as reported at the end of Q2 2026.